Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K - AIkido Pharma Inc. | a12-22271_28ka.htm |
Exhibit 99.2
Effect of the reverse stock split on the number of shares of common stock authorized, issued and outstanding and on the number of weighted average shares outstanding, basic and diluted, as reported in the December 31, 2011 Form 10-K and the June 30, 2012 Form 10-Q.
|
|
|
As Reported |
|
Restated |
| ||||||||
|
|
|
12/31/2011 |
|
12/31/2010 |
|
12/31/2011 |
|
12/31/2010 |
| ||||
|
Common Stock, $0.01 par value |
|
|
|
|
|
|
|
|
| ||||
|
Authorized shares |
|
50,000,000 |
|
50,000,000 |
|
2,500,000 |
|
2,500,000 |
| ||||
|
Shares issued |
|
3,103,004 |
|
2,143,631 |
|
155,150 |
|
107,182 |
| ||||
|
Shares outstanding |
|
3,094,961 |
|
2,135,588 |
|
154,748 |
|
106,779 |
| ||||
|
Treasury stock |
|
8,043 |
|
8,043 |
|
402 |
|
402 |
| ||||
|
|
|
|
|
|
| ||||||||
|
|
|
Year Ended December 31, |
|
Year Ended December 31, |
| ||||||||
|
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
| ||||
|
Weighted average shares outstanding, basic and diluted |
|
2,625,691 |
|
1,806,132 |
|
131,285 |
|
90,307 |
| ||||
|
Net loss per share, basic and diluted |
|
$ |
(1.32 |
) |
$ |
(4.28 |
) |
$ |
(26.37 |
) |
$ |
(85.67 |
) |
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
6/30/2012 |
|
|
|
6/30/2012 |
|
|
| ||||
|
Common Stock, $0.01 par value |
|
|
|
|
|
|
|
|
| ||||
|
Authorized shares |
|
50,000,000 |
|
|
|
2,500,000 |
|
|
| ||||
|
Shares issued |
|
4,167,820 |
|
|
|
208,391 |
|
|
| ||||
|
Shares outstanding |
|
4,159,777 |
|
|
|
207,989 |
|
|
| ||||
|
Treasury stock |
|
8,043 |
|
|
|
402 |
|
|
| ||||
|
|
|
3 months ended June 30, |
|
3 months ended June 30, |
| ||||||||
|
|
|
2012 |
|
2011 |
|
2012 |
|
2011 |
| ||||
|
Weighted average shares outstanding, basic and diluted |
|
4,159,777 |
|
2,562,488 |
|
207,989 |
|
128,124 |
| ||||
|
Net loss per share, basic and diluted |
|
$ |
(0.18 |
) |
$ |
(0.40 |
) |
$ |
(3.59 |
) |
$ |
(7.91 |
) |
|
|
|
6 months ended June 30, |
|
6 months ended June 30, |
| ||||||||
|
|
|
2012 |
|
2011 |
|
2012 |
|
2011 |
| ||||
|
Weighted average shares outstanding, basic and diluted |
|
3,940,898 |
|
2,505,568 |
|
197,045 |
|
125,278 |
| ||||
|
Net loss per share, basic and diluted |
|
$ |
(0.48 |
) |
$ |
(0.50 |
) |
$ |
(9.66 |
) |
$ |
(9.97 |
) |